欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/5565/001
药品名称
Ciprofloxacina Aurobindo
活性成分
ciprofloxacin hydrochloride 250.0 mg
剂型
Film-coated tablet
上市许可持有人
Aurobindo Pharma (Portugal), Unipessoal, Lda.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Bulgaria (BG)
Portugal (PT)
Belgium (BE)
Ciprofloxacine AB 250mg filmomhulde tabletten, comprimés pelliculés, Filmtabletten
Luxembourg (LU)
Spain (ES)
Romania (RO)
CIPROFLOXACINA AUROBINDO
许可日期
2015/06/17
最近更新日期
2023/10/11
药物ATC编码
J01MA02 ciprofloxacin
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Product Information
|
Clean_Ciprofloxacin Aurobindo film_coated tablets_Lab
Date of last change:2024/09/06
Final Product Information
|
Clean_Ciprofloxacin Aurobindo film_coated tablets_PIL
Date of last change:2024/09/06
Final Product Information
|
Clean_Ciprofloxacin Aurobindo film_coated tablets_SPC
Date of last change:2024/09/06
Final SPC
|
common_spc_annotated
Date of last change:2024/09/06
Final PL
|
Common PIL
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase